The Linea D'Arabo is Mansory's first complete model based on the refreshed-for-this-year Cullinan SUV. It has Arabic script, ...

For the year, the company reported that its loss widened to $167.4 million, or $2.78 per share. Cullinan Therapeutics shares have fallen 31% since the beginning of the year. The stock has declined ...

Net loss attributable to Cullinan was $47.6 million for the fourth quarter of 2024, compared to $23.8 million for the same period in 2023, and $167.4 million for the full year 2024, compared to $ ...

Charles Schwab Investment Management Inc. lifted its stake in Cullinan Therapeutics by 14.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 423,959 shares of the ...